OLZAPAR 150 TABLET 60'S

Nausea, vomiting, lethargy, diarrhea, appetite loss, and blood cell count abnormalities are typical adverse effects.

There are no specific dietary restrictions associated with OLZAPAR 150 TABLET 60'S. However, it's essential to maintain a healthy and balanced diet to support your overall well-being during treatment. It is recommended to avoid grape juice as it increases the blood drug concentration.

OLZAPAR 150 TABLET 60'S Tablet is usually indicated as maintenance therapy after a person completes a platinum-based chemotherapy regimen for ovarian cancer. However, newer studies are evaluating its solitary efficacy in treating different types of cancers.

There is NULL interaction of OLZAPAR 150 TABLET 60'S with other drugs

OLZAPAR 150 TABLET 60'S can lower blood cell counts, thus it's best to get blood tests done at regular intervals. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. OLZAPAR 150 TABLET 60'S should not be stopped without first talking to your doctor. When using this medication, stay away from grapefruit juice as it may raise your blood levels of the drug. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping OLZAPAR 150 TABLET 60'S. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, OLZAPAR 150 TABLET 60'S can be an effective treatment option for certain types of cancer.

OLAPARIB is molecule/combination used for making OLZAPAR 150 TABLET 60'S.

Olaparib is a PARP inhibitor used to treat certain types of cancer.

OLZAPAR 150 TABLET 60'S is typically prescribed to treat Ovarian cancer.